Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Daniel Fowler

Combination Gene Therapy and Th1/Th2 Therapy

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies

Karen Leslie Syrjala

Internet Studies to Enhance Long Term Survivorship after Hematologic Malignancy

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Catherine Ju-Ying Wu

Personal tumor neoantigens for immunity against chronic lymphocytic leukemia

Leukaemia

Thomas J Kipps

Chronic Lymphocytic Leukemia Research Consortium

Leukaemia

Hematology and hematologic malignancies Pathology

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies Pathology

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Joseph H Antin

A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma